[1] Senaratna CV, Perret JL, Lodge CJ, et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev. 2017;34:70–81.
[2] Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):e714–755.
[3] Huang W, Liu Y, Xu H, et al. Association of the serum irisin level with obstructive sleep apnea: A body mass index- and physical activity-matched study. Endocr J. 2020;67(6):607–612.
[4] Bagai K. Obstructive sleep apnea, stroke, and cardiovascular diseases. Neurologist. 2010;16(6):329–339.
[5] Parrino L, Vaudano AE. The resilient brain and the guardians of sleep: New perspectives on old assumptions. Sleep Med Rev. 2018;39:98–107.
[6] Bathory E, Tomopoulos S. Sleep regulation, physiology and development, sleep duration and patterns, and sleep hygiene in infants, toddlers, and preschool-age children. Curr Probl Pediatr Adolesc Health Care. 2017;47(2):29–42.
[7] Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events – deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597–619.
[8] Blunden S, Galland B. The complexities of defining optimal sleep: Empirical and theoretical considerations with a special emphasis on children. Sleep Med Rev. 2014;18(5):371–8.
[9] Wigren HK, Porkka-Heiskanen T. Novel concepts in sleep regulation. Acta Physiol (Oxf). 2018;222(4):e13017.
[10] Léger D, Debellemaniere E, Rabat A, Bayon V, Benchenane K, Chennaoui M. Slow-wave sleep: From the cell to the clinic. Sleep Med Rev. 2018;41:113–132.
[11] Wang F, Xiong X, Xu H, et al. The association between obstructive sleep apnea syndrome and metabolic syndrome: A confirmatory factor analysis. Sleep Breath. 2019;23(3):1011–1019.
[12] Whitaker KM, Lutsey PL, Ogilvie RP, et al. Associations between polysomnography and actigraphy-based sleep indices and glycemic control among those with and without type 2 diabetes: The multi-ethnic study of atherosclerosis. Sleep. 2018;41(11).
[13] Leng Y, McEvoy CT, Allen IE, Yaffe K. Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: A systematic review and meta-analysis. JAMA Neurol. 2017;74(10):1237–1245.
[14] Wu L, Sun D, Tan Y. A systematic review and dose-response meta-analysis of sleep duration and the occurrence of cognitive disorders. Sleep Breath. 2018;22(3):805–814.
[15] Barger LK, Rajaratnam SMW, Cannon CP, et al. Short sleep duration, obstructive sleep apnea, shiftwork, and the risk of adverse cardiovascular events in patients after an acute coronary syndrome. J Am Heart Assoc. 2017;6(10).
[16] Diekelmann S, Born J. The memory function of sleep. Nat Rev Neurosci. 2010;11(2):114–126.
[17] Ju YS, Ooms SJ, Sutphen C, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain. 2017;140(8):2104–2111.
[18] Raison CL, Rye DB, Woolwine BJ, et al. Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: Association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry. 2010;68(10):942–949.
[19] Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci USA. 2008;105(3):1044–1049.
[20] Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303–307.
[21] Subramanian S, Hesselbacher S, Mattewal A, Surani S. Gender and age influence the effects of slow-wave sleep on respiration in patients with obstructive sleep apnea. Sleep Breath. 2013;17(1):51–56.
[22] Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Häring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12(12):721–737.
[23] Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol. 2004;160(6):521–530.
[24] Shaw ND, McHill AW, Schiavon M, et al. Effect of slow wave sleep disruption on metabolic parameters in adolescents. Sleep. 2016;39(8):1591–1599.
[25] Gonnissen HK, Mazuy C, Rutters F, Martens EA, Adam TC, Westerterp-Plantenga MS. Sleep architecture when sleeping at an unusual circadian time and associations with insulin sensitivity. PLoS One. 2013;8(8):e72877.
[26] Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes. 2010;59(9):2126–2133.
[27] Chung KF. Use of the Epworth Sleepiness Scale in Chinese patients with obstructive sleep apnea and normal hospital employees. J Psychosom Res. 2000;49(5):367–372.
[28] Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep. 1997;20(10):844–849.
[29] Xu H, Zhao X, Shi Y, et al. Development and validation of a simple-to-use clinical nomogram for predicting obstructive sleep apnea. BMC Pulm Med. 2019;19(1):18.
[30] Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57–63.
[31] McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460–464.
[32] Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058.
[33] Ho V, Crainiceanu CM, Punjabi NM, Redline S, Gottlieb DJ. Calibration model for apnea-hypopnea indices: Impact of alternative criteria for hypopneas. Sleep. 2015;38(12):1887–1892.
[34] Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670–676.
[35] Zou J, Xia Y, Xu H, et al. Independent relationships between cardinal features of obstructive sleep apnea and glycometabolism: A cross-sectional study. Metabolism. 2018;85:340–347.
[36] Gaines J, Vgontzas AN, Fernandez-Mendoza J, Bixler EO. Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev. 2018;42:211–219.
[37] Huang WY, Zou X, Lu FE, et al. Jiao-tai-wan up-regulates hypothalamic and peripheral circadian clock gene cryptochrome and activates PI3K/AKT signaling in partially sleep-deprived rats. Curr Med Sci. 2018;38(4):704–713.
[38] Benedict C. Antihypertensive medication prior to nocturnal sleep reduces the risk of new-onset type 2 diabetes in hypertensive patients: A role for slow-wave sleep? Diabetologia. 2016;59(2):390–391.
[39] Hermida RC, Ayala DE, Mojón A, Fernández JR. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: A randomised controlled trial. Diabetologia. 2016;59(2):255–265.
[40] Leproult R, Holmbäck U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. 2014;63(6):1860–1869.
[41] Brager AJ, Ehlen JC, Castanon-Cervantes O, et al. Sleep loss and the inflammatory response in mice under chronic environmental circadian disruption. PLoS One. 2013;8(5):e63752.
[42] Qian J, Scheer F. Circadian system and glucose metabolism: Implications for physiology and disease. Trends Endocrinol Metab. 2016;27(5):282–293.
[43] Zhu Y, Li AM, Au CT, et al. Association between sleep architecture and glucose tolerance in children and adolescents. J Diabetes. 2015;7(1):10–15.
[44] Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: From obesity to diabetes. Am J Hypertens. 2001;14(11 Pt 2):304s-309s.
[45] Matthews KA, Dahl RE, Owens JF, Lee L, Hall M. Sleep duration and insulin resistance in healthy black and white adolescents. Sleep. 2012;35(10):1353–1358.
[46] Shaver JL, Woods NF. Sleep and menopause: A narrative review. Menopause. 2015;22(8):899–915.
[47] Ley SH, Li Y, Tobias DK, et al. Duration of reproductive life span, age at menarche, and age at menopause are associated with risk of cardiovascular disease in women. J Am Heart Assoc. 2017;6(11).